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Abstract
Phospholipase C-related inactive protein (PRIP) plays important roles in trafficking to the plasma membrane of GABAA
receptor, which is involved in the dominant inhibitory neurotransmission in the spinal cord and plays an important
role in nociceptive transmission. However, the role of PRIP in pain sensation remains unknown. In this study, we
investigated the phenotypes of pain behaviors in PRIP type 1 knockout (PRIP-1 -/- ) mice. The mutant mice showed
hyperalgesic responses in the second phase of the formalin test and the von Frey test as compared with those in
wild-type mice. In situ hybridization studies of GABAA receptors revealed significantly decreased expression of g2
subunit mRNA in the dorsal and ventral horns of the spinal cord in PRIP-1 -/- mice, but no difference in a1 subunit
mRNA expression. b2 subunit mRNA expression was significantly higher in PRIP-1 -/- mice than in wild-type mice in all
areas of the spinal cord. On the other hand, the slow decay time constant for the spontaneous inhibitory current was
significantly increased by treatment with diazepam in wild-type mice, but not in PRIP-1 -/- mice. These results suggest
that PRIP-1 -/- mice exhibit the changes of the function and subunits expression of GABAA receptor in the spinal cord,
which may be responsible for abnormal pain sensation in these mice.
Findings
Neuropathic pain is a critical disease that is induced by
cancer, diabetes, infection or nerve damage [1]. Many stu-
dies have suggested that neuropathic pain occurs as a
result of functional and/or anatomical changes in the pri-
mary sensory ganglia and the dorsal horn of the spinal
cord after peripheral nerve injury [2-5]. One of these
changes is the activation of microglia in the spinal dorsal
horn. These microglia enhance the expression of neuro-
transmitter receptors and intracellular signaling kinases
[6-8]. Changes in the expression of neurotransmitter (e.g.,
glutamate, ATP and GABA) receptors also occur in the
dorsal root ganglion neurons or the spinal neurons [9-12].
GABA is the predominant inhibitory neurotransmitter in
the spinal cord and in nociceptive transmission [13-16].
Accordingly, inhibition of GABAA receptors results in
hypersensitivity of dorsal horn neurons and allodynia
[17-20]. Therefore, reduced GABAergic input to the dorsal
horn of the spinal cord is considered to be an important
factor in the induction of allodynia.
Phospholipase C (PLC)-related inactive protein (PRIP)
was first identified as a novel inositol 1,4,5-trisphospate
[Ins(1,4,5)P3] binding protein, which is homologous to
PLC-δ1, but is catalytically inactive [21]. The PIRP family
consists of at least two types of proteins, PRIP-1 and
PRIP-2. PRIP-1 is predominantly expressed in the brain,
while PRIP-2 is ubiquitously expressed [22,23]. PRIP-1 has
a number of binding partners that include the catalytic
subunit of protein phosphatase 1a and GABAA receptor-
associated protein [24]. This prompted us to examine the
possible involvement of PRIP in GABAA receptor func-
tion. One role of PRIP-1 in regulating GABAA receptor
functions was suggested based on the changes in GABAA
receptor pharmacology and behavior in PRIP-1 knockout
(PRIP-1 -/- ) mice [24,25]. It is possible that PRIP-1 -/- mice
exhibit abnormal pain sensation because of altered
GABAA receptor functions in the central nervous system
(CNS). Therefore, in this study, we examined the
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phenotypes of pain behavior and GABAA receptor subunit
mRNA expression in PRIP-1 -/- mice.
To determine how PRIP-1 affects acute nociceptive
hypersensitivity, we first performed the plantar formalin
test in PRIP-1 -/- and wild-type mice (Figure 1A). Intra-
plantar injection of formalin evoked biphasic licking and
biting behaviors. The first and second phases lasted 5 min
and 60 min, respectively, after formalin injection. PRIP-1
-/- mice failed to show changes in the first phase, but the
second phase response was significantly greater and the
peak of the second phase occurred earlier in PRIP-1 -/-
mice than in wild-type mice.
The hot plate test was performed at five different tem-
peratures (46, 48, 50, 52 and 55°C) (Figure 1B). The
latency to hindpaw licking was temperature-dependent
and no difference was observed at 46, 48, 52 or 55°C
between PRIP-1 -/- and wild-type mice. On the other hand,
the mutant mice tended to be hypersensitive at 50°C,
although this was not statistically significant.
To determine whether PRIP-1 plays a role in the beha-
vioral responses to mechanical stimuli, the von Frey test
was performed in PRIP-1 -/- mice and in wild-type mice
(Figure 1C). Mechanical paw withdrawal thresholds were
significantly lower in PRIP-1 -/- mice than in wild-type
mice. Next, to investigate the influence of PRIP-1 on tac-
tile allodynia during neuropathic pain, we performed par-
tial sciatic nerve ligation (PSNL) in PRIP-1 -/- mice and in
wild-type mice (Figure 1D). Wild-type mice showed a sig-
nificant decrease in ipsilateral paw withdrawal threshold
after PSNL, which started at least 3 days after PSNL and
lasted for more than 10 days. Although PRIP-1 -/- mice
showed greater hypersensitivity than wild-type mice, the
PRIP-1 -/- mice also showed a strong decrease in ipsilateral
paw withdrawal threshold after PSNL. This effect started
at least 7 days after PSNL and lasted for more than 7 days.
Previous studies showed that transport of the GABAA
receptor g subunit was altered in PRIP-1 -/- mice, thus
reducing the sensitivity to benzodiazepine [25,26]. The
majority of GABAA receptors in the CNS are believed to
consist of a1, b2, and g2 subunits [27]. Therefore, we
investigated the mRNA expression patterns of these
GABAA receptor subunits in the spinal cord of PRIP-1
-/-
mice and in wild-type mice (Figure 2). a1, b2 and g2 subu-
nit mRNA expression was observed in the dorsal horn,
intermediate gray matter and ventral horn of the spinal
cord in these mice. There were no differences in a1 subu-
nit mRNA expression between PRIP-1 -/- mice and wild-
type mice. On the other hand, b2 subunit mRNA expres-
sion was significantly greater in PRIP-1 -/- mice than in
wild-type mice throughout the spinal cord. In contrast,
mRNA expression of the g2 subunit was significantly
decreased in the dorsal and ventral horns of the spinal
cord in PRIP-1 -/- mice compared with wild-type mice.
Spontaneous inhibitory postsynaptic currents (sIPSCs)
were recorded as outward currents from 56 substantia
geratinosa (SG) neurons, the lamina II of the spinal dor-
sal horn, with cells held at 0 mV. Exposure to 20 μM
bicuculline methiodide (BMI) shifted the baseline hold-
ing current (Figure 3A), and this shift tended to be
smaller in PRIP-1 -/- mice (3.7 ± 0.6 pA, n = 14) than in
wild-type mice (4.7 ± 1.3 pA, n = 23), although it was
not statistically significant. After administering 2 μM
strychnine to block glycine receptors, the baseline shift
was not significantly different between wild-type (0.8 ±
0.7 pA, n = 4) and PRIP-1 -/- mice (-0.4 ± 1.3 pA, n = 5).
Next, we examined the effects of diazepam (DZP) on
GABAergic sIPSCs in SG neurons (Figure 3B). The mean
sIPSCs were best fit into a two-exponential equation.
Tau2 was significantly increased by 1 μM DZP in wild-
type mice (control: 39.3 ± 8.7 ms, n = 6; DZP: 98.4 ±
20.5 ms, n = 6), but not in PRIP-1 -/- mice (control: 51.6 ±
14.6 ms, n = 6; DZP: 44.2 ± 14.7 ms, n = 6). Tau1 was not
affected by DZP in wild-type (control: 7.6 ± 1.3 ms, n = 6;
DZP: 11.9 ± 2.9 ms, n = 6) or in PRIP-1 -/- mice (control:
12.0 ± 2.1 ms, n = 6; DZP: 10.0 ± 1.9 ms, n = 6). The 10-
90% rise time was not significantly affected by DZP in
wild-type (control: 2.9 ± 0.6 ms, n = 6; DZP: 2.7 ± 0.6 ms,
n = 6) and PRIP-1 -/- mice (control: 2.8 ± 0.4 ms, n = 6;
DZP: 2.9 ± 0.5 ms, n = 6). Peak amplitude was also unaf-
fected by DZP in wild-type (control: 17.1 ± 3.3 pA, n = 6;
DZP: 11.4 ± 1.2 pA, n = 6) and PRIP-1 -/- mice (control
19.4 ± 5.1 pA, n = 6; DZP: 22.9 ± 6.3 pA, n = 6). Further-
more, frequency was not significantly affected by DZP in
wild-type (control: 0.11 ± 0.02 Hz, n = 6; DZP: 0.09 ± 0.02
Hz, n = 6) and PRIP-1 -/- mice (control: 0.3 ± 0.1 Hz, n =
6; DZP: 0.2 ± 0.1 Hz, n = 6).
PRIP was reported to facilitate the transport of the g2
subunit-containing GABAA receptor [25,26]. It is thought
that the functions of the GABAA receptor are highly influ-
enced by PRIP. GABA plays an important role in nocicep-
tive transmission in the spinal cord as an inhibitory
neurotransmitter [13-20]. Thus, we investigated the role of
PRIP-1 on acute or chronic pain using PRIP-1 -/- mice.
We found that the second phase, but not the first phase,
of the licking and biting responses following intraplantar
formalin injection was significantly increased in PRIP-1 -/-
mice. Intraplantar injection of formalin evokes nociceptive
behaviors in rodents such as licking, biting and lifting of
the injected paw in a biphasic manner. The first phase of
the response is caused by persistent activation and acute
sensitization of nociceptors, while the second phase is
caused by continual activation of the nociceptors and sen-
sitization of the central synapses via mechanisms triggered
by repetitive stimulation during the first phase [28]. There-
fore, the hyperalgesic response in PRIP-1 -/- mice induced
by intraplantar injection of formalin may occur via central
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Figure 1 Chemical, thermal and mechanical-induced pain and PSNL-induced tactile allodynia in PRIP-1 -/- mice and wild-type mice. (A)
Duration of licking and biting responses for each 5-min interval after intraplantar injection of formalin in PRIP-1 -/- mice (n = 14) and wild-type
mice (n = 10). Each point represents the mean and S.E.M. (*P < 0.05 vs. wild-type). (B) Hindpaw licking latency was measured at five
temperatures (46, 48, 50, 52 and 55°C). Each value represents the mean and S.E.M. (n = 6-10). (C) Paw withdrawal threshold in response to tactile
stimulation with von Frey filaments in PRIP-1 -/- mice (n = 6) and wild-type mice (n = 6). Each value represents the mean and S.E.M. (*P < 0.05 vs.
contralateral side). (D) Paw withdrawal threshold in response to tactile stimulation with von Frey filaments in PRIP-1 -/- mice (n = 5-7) and wild-
type mice (n = 8-14) before (0) and 3, 7 and 14 days after PSNL. Each point represents the mean and S.E.M. (*P <0.05, **P <0.01 vs. the
contralateral side, n = 6-10).
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pathways. On the other hand, the thermal sensitivity dur-
ing the hotplate test at five different temperatures was not
significantly different between PRIP-1 -/- mice and wild-
type mice. The responses to the hotplate test involve more
complex behavior [29,30]. It has been reported that dys-
function of the GABAA receptor can affect heat nocicep-
tion [31]. However, we found that deficiency in PRIP-1 did
not affect responses to noxious heat stimulation. In our in
situ hybridization experiment, the mRNA expression of g2
subunit was decreased in the dorsal horn of the spinal
cord in PRIP-1 -/- mice, whereas that of b2 subunit was
increased. Our results raise the possibility that the activity
of the GABAA receptor containing the g2 subunit during
thermal nociception in PRIP-1 -/- mice may be compen-
sated for by the GABAA receptor composed of the others
subunits containing the b2 subunit. Furthermore, although
the mechanical paw withdrawal threshold was decreased
in PRIP-1 -/- mice, the ipsilateral hypersensitive reaction
was more pronounced in PRIP-1 -/- mice after PSNL.
These results suggest that tactile allodynia is affected by
PRIP-1 deficiency.
The GABAA receptor is a heterooligomeric complex of
five subunits and the majority of the receptors in the CNS
are thought to consist of a1, b2 and g2 subunits [27]. We
found no differences in a1 subunit mRNA expression
between PRIP-1 -/- mice and wild-type mice, whereas b2
subunit mRNA expression was significantly greater in
PRIP-1 -/- mice than in wild-type mice throughout the
spinal cord. Further studies are required to elucidate the
mechanism involved in this change in expression. Interest-
ingly, g2 subunit mRNA expression in the dorsal and ven-
tral horns of the spinal cord was significantly lower in
PRIP-1 -/- mice than in wild-type mice. The g2 subunit is
an important factor that regulates the benzodiazepine
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Figure 2 mRNA expression of the GABA A receptor a1, b2 and g2 subunits in the spinal cord of PRIP-1 -/- mice and wild-type mice. (A)
Representative film autoradiograms showing the mRNA expression of GABAA receptor a1, b2 and g2 subunits. (B) Semiquantitative analysis of
GABAA receptor a1, b2, and g2 subunit mRNA expression in the dorsal horn (DH), intermediate gray matter (IG) and ventral horn (VH) of the spinal
cord in PRIP-1 -/- mice (black) and wild-type mice (white). Each value represents the mean and S.E.M. (*P < 0.05 , **P < 0.01 vs. wild-type, n = 3).
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Figure 3 Inhibitory synaptic and extrasynaptic currents in SG neurons of PRIP-1 -/- mice and wild-type mice. (A) Representative traces
and expanded traces for wild-type (left) and PRIP-1 -/- (right) showing the shift in baseline holding current elicited by 20 μM BMI and/or 2 μM
strychnine (stry). The bar graph shows baseline shift elicited by 20 μM BMI (wild-type, n = 23; PRIP-1 -/- , n = 14) and/or 2 μM strychnine (wild-
type, n = 6; PRIP-1 -/- , n = 6). BMI and strychnine were applied for 3-5 min in each experiment. (B) Representative traces and mean sIPSCs for
wild-type (left) and PRIP-1 -/- (right) mice showing the sIPSCs elicited by 1 μM DZP. Tau is the decay time constant for the averaged trace of all
sIPSCs recorded over 1 min in the absence or presence of DZP. DZP was applied for 8-10 min in each experiment. The red line in the averaged
sIPSC trace shows the curve derived from a double-exponential equation. The bar graph shows summary of the tau data. Bars represent means
and S.E.M. (*P < 0.05 vs. control, n = 6; †P < 0.05 vs. wild-type, n = 6).
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sensitivity to GABAA receptors, as well as receptor expres-
sion and trafficking [32]. Thus, it is thought that the
assembly of GABAA receptors containing the g2 subunit,
as well as the functions of this receptor, are impaired in
the spinal cord of PRIP-1 -/- mice. Ataka et al. [33]
reported that phasic inhibition is mediated by both
GABAergic and glycinergic inhibitory postsynaptic cur-
rents, and that the tonic inhibitory currents are mediated
by GABAA receptors in the dorsal horn lamina II region
of the spinal cord. We thus investigated the tonic inhibi-
tory currents in SG neurons of PRIP-1 -/- mice. These cur-
rents were achieved by the application of BMI, but not by
strychnine, and tended to be smaller in PRIP-1 -/- mice
than wild-type mice, although not statistically significant.
This suggests that the function of GABAA receptors con-
taining the g2 subunit may be compensated for by the
GABAA receptor containing b2 subunit in terms of tonic
inhibition in PRIP-1 -/- mice. Recently, it is reported that
the GABAA receptor δ subunit in the spinal cord mediated
tonic inhibition and acute nociception [34]. Tonic inhibi-
tory currents mediated by GABAA receptors in spinal neu-
rons play an important role in the regulation of acute
nociception and central sensitization. Therefore, it is pos-
sible that PRIP-1 knockout may partially influence of tonic
inhibition with some of GABAA receptor subunits. On the
other hand, the prolonged Tau2 induced by DZP in wild-
type mice was absent in PRIP-1 -/- mice. In previous stu-
dies, three types of IPSCs, including glycine receptor-
mediated, GABAA receptor-mediated and mixed type,
were recorded from lamina II neurons [33,35]. GABAA
receptor-mediated IPSCs showed slow decay time con-
stant, while glycine receptor-mediated IPSCs were rapid.
Our results suggest that the assembly of GABAA receptor
containing g2 subunit impaired by PRIP-1 knockout may
occur the impairment of the function of GABAA receptor
in the spinal cord. However, tonic inhibition and kinetics
of IPSC were not significantly difference between wild-
type and PRIP-1 -/- mice. Therefore, it is thought that the
hyperalgesic reactions observed in PRIP-1 -/- mice may
involve in other factors in addition to the impairment of
GABAergic transmission in the spinal cord of these mice.
In conclusion, we have demonstrated that PRIP-1 -/-
mice show behavioral abnormalities in response to various
noxious stimuli. It is possible that these behaviors in PRIP-
1 -/- mice are dependent on changes in the subunits
expression and the function of GABAA receptor in the
spinal cord. Therefore, defects in PRIP-1, which plays a
role in the assembly of the GABAA receptor, are responsi-
ble for abnormal behaviors in response to pain.
Methods and Materials
Animals
PRIP-1 -/- mice were used in our experiments. Mice
were housed at 24 ± 2°C with a 12/12-h light/dark cycle
(lights on at 8:00 am), and were given free access to
commercial food and tap water. The experimental pro-
cedures were based on the Guidelines of the Committee
for Animal Care and Use of Hirosaki University, Hir-
oshima University and Kyushu University.
Formalin test
Each mouse was placed in a clear plastic cage at least 30
min before the formalin injection to allow it to adapt to
the new environment. A solution of 5% formalin in saline
(50 μl) was injected into the plantar surface of the right
hindpaw. The number of flinches (rapid paw shaking) of
the injected paw was recorded as a pain-related behavior.
The total number of hind paw flinches was determined
during twelve 5-min intervals for 60 min after formalin
injection.
Hotplate test
The hotplate tests were performed at five different tem-
peratures (46, 48, 50, 52 and 55°C) (Hot Plate Analgesia
Meter MK-350C, Muromachi Kikai Co., Ltd, Tokyo,
Japan). The latency to licking of the hindpaw was
recorded. To prevent tissue damage, the cut-off time was
60 s for 50°C, 40 s for 52°C, and 30 s for 55°C. Animals
not responding within the cutoff time were removed and
assigned a score of the cutoff time.
von Frey test
Mechanical sensitivity was determined using von Frey fila-
ments (Semmes-Weinstein monofilaments, Stoelting, IL,
USA) with calibrated bending forces (g), as previously
described [36]. In brief, the mice were placed individually
in a glass cage with a wire-mesh bottom. After the mice
had adapted to the testing environment for 60 min, a ser-
ies of von Frey filaments (0.008, 0.02, 0.04, 0.07, 0.166,
0.407, 0.692, 1.202, 1.479 and 2.0 g) were pressed perpen-
dicularly against the mid-planter surface of the hind paw
from below the mesh floor and held for 3-5 s with the fila-
ment slightly buckled. Lifting of the paw was recorded as a
positive response. The paw withdrawal threshold was
defined as the minimum pressure required to elicit a with-
drawal reflex of the paw, at least once in five trials.
PSNL
The mice were anesthetized with an intraperitoneal
injection of pentobarbital (60 mg/kg). Under a light
microscope (SD30; Olympus, Tokyo, Japan), a tight liga-
ture was made using an 8-0 silk suture around approxi-
mately 1/3-1/2 of the diameter of the sciatic nerve
located on the right-hand side. This method is similar
to that described by Seltzer et al. [37]. In sham-operated
mice, the nerve was exposed without ligation.
In situ hybridization
Mice were killed by decapitation. The lower lumbar seg-
ment (L3-L5) of the spinal cord was immediately
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resected and frozen in liquid nitrogen and stored at
-80°C. Sections (20 μm thick) were cut from each nerve
tissue block through L4 using a microtome cryostat
(Microm HM500 OM, Walldorf, Germany). The sec-
tions were thaw-mounted onto APS-coated slides (Mat-
sunami, Japan) and stored at -30°C until used for in situ
hybridization. For in situ hybridization histochemistry,
specific oligonucleotides were selected from the follow-
ing sequences: GABAA receptor a1 subunit GGGGT
CACCCCTGGCTAAGTTAGGGGTATAGCTGGTTG
CTGTAGG; GABAA receptor b2 subunit TCGTTCC
AGGGCGTTGCGGCCAAAACTATGCCTAGGCAAC
CCAGC; GABAA receptor g2 [NDS1] subunit CATTTG-
GATCGTTGCTGATCTGGGACGGATATCAATGG-
TAGGGGC. The oligonucleotide probes were labeled
with [33P]-dATP (2000 Ci/mmol; {DuPont-NEN}[NDS2])
and terminal deoxynucleotidyltransferase (Boehringer
Mannheim, Germany). The labeled probes were purified
using a QIAquick Nucleotide Removal Kit (Qiagen
GmbH, Hilden, Germany). Hybridization was performed
as previously described [38], except that the purified
probes were diluted to a final concentration of 107 cpm/
ml before use. The hybridized sections were exposed to
Kodak BioMAX MR films at -80°C and a Kodak MS
screen was used to increase the intensity of the hybridi-
zation signals. The films were exposed for 7-10 days and
then developed. The optical density of the hybridization
signals from three sections (the dorsal horn, the inter-
mediate gray matter and the ventral horn of the L4
region) was acquired using an Epson GT-9800 scanner
(Epson, Japan). The density was determined using NIH
Image (Bethesda, MD, USA) on a Macintosh G5 compu-
ter (Apple Computer, Vancouver, WA, USA). The
intensity was calculated relative to the background
signal.
Electrophysiology
Transverse spinal cord slices were obtained from the L4
and L5 spinal cords of 5-8-week-old mice. Each mouse
was deeply anesthetized with halothane, decapitated, and
the lumbar spinal cord (L1-L6) was removed. After
removing the pia-arachnoid membrane, 450-μm-thick
spinal cord slices were cut on a brain slicer (VIBRA-
TOME [NDS3] 3000 SERIES) in ice-cold oxygenated
sucrose-substituted artificial cerebrospinal fluid (ACSF).
This solution contained (in mM): 250 sucrose, 2.5 KCl, 1
NaH2PO4, 1 MgCl2, 2.5 CaCl2, 25 NaHCO3 and 10 glu-
cose. The solution was bubbled with 95% O2 and 5%
CO2. Slices were incubated for at least 1 h in a storage
chamber containing ACSF composed of (in mM): 117
NaCl, 3.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.5 CaCl2, 25
NaHCO3 and 11 glucose, with 95% O2/5% CO2 at room
temperature before recording. A spinal cord slice
was transferred to a recording chamber and perfused
(5 ml/min) with ACSF at room temperature. SG neurons
were viewed on a monitor via a 40 × water-immersion
objective lens with an infrared differential interference
contrast filter and a CCD camera (ORCA-ER C4742-95,
Hamamatsu Photonics, Shizuoka, Japan). Patch pipettes
(resistance: 3-5 MΩ), made from borosilicate glass
(1.5 mm O.D, TW150-3, World Precision Instruments,
{Inc, USA}[NDS4]) was filled with an internal solution con-
taining (in mM): 150 CsCH3SO3, 5 KCl, 3 MgCl2, 0.1
EGTA and 10 HEPES, 3 Mg(ATP)2 and 0.4 NaGTP (pH
7.3 with 1 M CsOH). Membrane currents were recorded
with cells held at 0 mV using a Multiclamp 700B (Mole-
cular Devices, Sunnyvale, CA, USA) and digitized at 5-10
kHz with DigiData1322A (Molecular Devices). Data were
stored and analyzed using pClamp9.2 software (Molecu-
lar Devices), Igor Pro software (WaveMetrics, Inc, Lake
Oswego, OR, USA) and {NeuroMatic version 2.00 soft-
ware}[NDS5]. Series resistance compensation was not
applied.
Statistical analysis
Statistical analysis of data was performed using the
Mann-Whitney U -test or Student’s t -test for compari-
sons between two groups, or analysis of variance fol-
lowed by Tukey’s test for multiple comparisons. Results
are expressed as means and standard error of the mean
(S.E.M.). The level of significance was set at P < 0.05 .
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